Deniz Peker, MD
-
RolePathology
-
Research Program
-
Practicing Since2012
Background
Deniz Peker, MD, is a professor in the Department of Pathology & Laboratory Medicine at Emory University School. Dr. Peker is board certified in hematopathology.
Dr. Peker received her Medical Degree from Erciyes University in Kayseri, Turkey. She completed her pathology residency at Istanbul University in Turkey, and at Mount Sinai Medical Center in Miami, Florida. She completed her hematopathology residency at Moffitt Cancer Center in Tampa, Florida.
Dr. Peker's research interest is in the biology and microenvironment in hematologic malignancies including leukemia, lymphoma and myeloma.
PubMed
Google Scholar
Titles & Roles
-
Professor, Department of Pathology and Laboratory MedicineEmory University School of Medicine
Education & Training
Education
- Residency, Pathology-Hematology, 2012Moffitt Cancer Center
- Fellowship, MD, Pathology, 2012University of South Florida College of Medicine
- Internship, Anatomic Pathology & Clinical Pathology, 2010Mount Sinai Medical Center
- Residency, Pathology, 2006Istanbul University Cerrahpasa Medical Faculty
- Externship program, 2006Mount Sinai Medical Center
- Externship program, 2003Nottingham University Hospitals NHS Trust
- Medical Education, 2002Erciyes University
Board Certifications
- HematopathologyAmerican Board of Pathology, 2012Anatomic and Clinical PathologyAmerican Board of Pathology, 2011
Research
Publications
Title/Journal Authors Publication Date Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
D Rivera, W Cui, J Gao, D Peker, QY Zhang, R Dewar, L Qiu, S Konoplev, Z Hu, K Sasaki, AY Hu, S E, M Liu, H Fang, W Wang, G Tang, JF Apperley, A Hochhaus, JE Cortes, JD Khoury, LJ Medeiros, E Jabbour, S Hu 02/01/2024 Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.
Blood cancer journal
T Zhou, CV Curry, M Khanlari, M Shi, W Cui, D Peker, W Chen, E Wang, J Gao, Q Shen, W Xie, FZ Jelloul, RL King, J Yuan, X Wang, C Zhao, IE Obiorah, EL Courville, E Nomura, S Cherian, ML Xu, WR Burack, HX Liu, EJ Jabbour, K Takahashi, W Wang, SA Wang, JD Khoury, LJ Medeiros, S Hu 01/25/2024 Current oncology reports
M Lee, A Abousaud, RA Harkins, E Marin, D Balasubramani, MC Churnetski, D Peker, A Singh, JL Koff 08/01/2023 T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
American journal of clinical pathology
Z Hu, LJ Medeiros, M Xu, J Yuan, D Peker, L Shao, Z Tang, B Mai, B Thakral, A Rios, S Hu, W Wang 04/04/2023 Laboratory medicine
OC Puglianini, D Peker, L Zhang, N Papadantonakis 01/05/2023 Archives of pathology & laboratory medicine
AA Gru, MS Lim, A Dogan, SM Horwitz, J Delabie, K Fu, D Peker, VVB Reddy, ML Xu, K Vij, GW Slack, RN Miranda, D Jagadeesh, JM Lisano, ED Hsi, E Torlakovic 01/01/2023 The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Blood
P Li, S Brown, M Williams, T White, W Xie, W Cui, D Peker, L Lei, CA Kunder, HY Wang, SS Murray, J Vagher, T Kovacsovics, JL Patel 08/18/2022 Leukemia
P Li, T White, W Xie, W Cui, D Peker, G Zeng, HY Wang, J Vagher, S Brown, M Williams, T Kovacsovics, JL Patel 03/01/2022 The need for new test verification and regulatory support for innovative diagnostics.
Nature biotechnology
JD Roback, EA Tyburski, D Alter, S Asakrah, A Chahroudi, A Esper, S Farmer, J Figueroa, J K Frediani, M D Gonzalez, D S Gottfried, J Guarner, N A Gupta, S S Heilman, C E Hill, R Jerris, R R Kempker, J Ingersoll, JM Levy, M Mavigner, C S Moreno, C R Morris, E J Nehl, A S Neish, D Peker, N Saakadze, PA Rebolledo, C A Rostad, N Schoof, A Suessmith, J Sullivan, YFW Wang, A Wood, MB Vos, O Brand, GS Martin, WA Lam 09/01/2021 Annals of clinical and laboratory science
F Fei, V Reddy, D Peker, C Patel, S Al Diffalha 01/01/2021 Turk patoloji dergisi
B Morales-Vargas, K Deeb, D Peker 01/01/2021 Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.